Fisher & Paykel Healthcare Corporation Limited (FPH)
All research reports and stock updates for Fisher & Paykel Healthcare Corporation Limited.
Stock Updates
Research Reports
Breathing easier
Fisher & Paykel Healthcare devotees are breathing easier after this interim result.
After the bubble
Fisher & Paykel Healthcare is facing the inevitable flipside of its two year COVID windfall.
Exhaling COVID
The COVID-driven tailwind of the past two years is unwinding quickly for Fisher & Paykel Healthcare. Consumable and hardware sales are falling as the now bloated hospital installed base adjusts to the post- COVID environment.
Glide path back to normal
FPH reported 1H22 net profit of NZ$221.8 million, a small 1.6% fall on the same COVID-boosted period last year. Hospital revenue again dominated the revenue mix at 74% of the group, but the divisional revenue was -2% on last year or -1% on a constant currency basis. Homecare revenue was basically flat but increased 3% on a CC basis.